Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2018-10-30
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The transition from regular cocaine use to cocaine abuse is often marked by intense episodes (binges), which may last several days and are followed by a 'crash' with no or little use. For many people, repeated administration of cocaine over a short duration of time creates vivid episodic memories of euphoria which can inform future craving content. Craving or strong urges are a distinctive feature of CUD and are often reported as involuntary, distressing and uncontrollable.
Research has demonstrated that craving experiences can be voluntarily evoked or elicited by conditioned drug cues in the environment and internal processes such mood or physical sensations. The associations between cues and use are established through classical and instrumental reward-based conditioning and are important for the development and maintenance of CUD. Enhanced attention to cocaine cues develops and remains heightened for at least six months into abstinence.
Craving-related experiences are informed by memories of intense reward, physical sensations and include pro-drug beliefs, appraisals, expectancies and vivid mental imagery. Drug-imagery is often initially pleasurable and affectively charged and can motivate drug-seeking behaviour. If impeded or delayed, drug imagery highlights a deficit and can be experienced as distressing and intrusive. Treatment of intrusive images has been successful in various psychological disorders using imagery rescripting. Imagery rescripting has recently been used in memory-focused cognitive therapy to help reduce cocaine craving. Reducing intrusive image-induced negative affect through positive imagery is important for relieving psychological distress but there is also evidence that aversive imagery may reduce maladaptive approach behaviours.
This will be a pragmatic, 4-week, 2x2, between-subjects, factorial randomised controlled trial. It will be conducted at a specialist NHS outpatient addictions clinic (Lorraine Hewitt House; LHH) operated by South London and Maudsley NHS Foundation trust (SLaM) and at the NIHR Wellcome Trust King's Clinical Research Facility (CRF) at King's College Hospital.
Informed consenting adult participants will be randomised to one of four conditions:
* future-based (prospective) recovery-oriented imagery;
* future-based (prospective) cocaine-aversive imagery;
* past (autobiographical) recovery-oriented imagery; or
* past (autobiographical) cocaine-aversive imagery.
Participants will undergo a craving induction procedure designed to elicit cue-induced craving. In response to elevated craving, participants will be asked to reduce their craving levels using a mental imagery intervention.
Following the procedure in the research facility, participants will be given a digital audio player to take home. This will contain a recording of the imagery condition they are allocated to. Participants will be asked to listen to this recording each day during a 14-day follow-up, and ad libertatem when experiencing cocaine craving. After 14 days participants will be invited for a follow up conducted at the community addictions clinic.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Future-based recovery-oriented imagery
Mental Imagery for Craving Reduction: mental imagery aimed at describing a future without cocaine use
Mental Imagery for Craving Reduction
a behavioural mental imagery intervention where participants are asked to generate specific mental images to reduce cue-induced craving for cocaine use disorder
Future-based cocaine-aversive imagery
Mental Imagery for Craving Reduction: mental imagery aimed at describing a future where cocaine is causing significant distress
Mental Imagery for Craving Reduction
a behavioural mental imagery intervention where participants are asked to generate specific mental images to reduce cue-induced craving for cocaine use disorder
Past recovery-oriented imagery
Mental Imagery for Craving Reduction: mental imagery aimed at describing a past event without cocaine use
Mental Imagery for Craving Reduction
a behavioural mental imagery intervention where participants are asked to generate specific mental images to reduce cue-induced craving for cocaine use disorder
Past cocaine-aversive imagery
Mental Imagery for Craving Reduction: mental imagery aimed at describing a past event where cocaine use has caused significant distress
Mental Imagery for Craving Reduction
a behavioural mental imagery intervention where participants are asked to generate specific mental images to reduce cue-induced craving for cocaine use disorder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mental Imagery for Craving Reduction
a behavioural mental imagery intervention where participants are asked to generate specific mental images to reduce cue-induced craving for cocaine use disorder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaking (to a level sufficient to engage with a psychosocial intervention);
* Current diagnosis for primary CUD alone, with concurrent opiate use disorder or while enrolled in opioid agonist therapy \*
* Self-reported regular use of crack cocaine;
* Stated motivation to reduce or quit cocaine use;
Exclusion Criteria
* Suicide attempt in the past 3 months;
* Participants with harmful alcohol consumption (\>50 units per week men; \>35 units women);
* Cocaine hydrochloride (powder form) users; \*\*
* Non-English Speaking;
* Clinically significant on-going medical problems that might make participation unsafe;
* Uncontrolled Mental Health Disorder;
* Severe neurocognitive impairment (Montreal Cognitive Assessment \<17);
* Current enrolment in an addiction treatment related clinical research study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South London and Maudsley NHS Foundation Trust
OTHER
King's College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Marsden
Role: PRINCIPAL_INVESTIGATOR
King's College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lorraine Hewitt House
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Luke Mitcheson, DCLinPsy
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18?LO/1013
Identifier Type: -
Identifier Source: org_study_id